top of page

Selected Publications

The PURE-01 study publications track

My group pioneered the use of neoadjuvant immunotherapy in early-stage, muscle invasive disease, through the PURE-01 trial. The study tested 3 cycles of neoadjuvant pembrolizumab prior to radical cystectomy. This study inspired several clinical trials that are currently being offered to patients diagnosed with muscle-invasive bladder cancer

2018

2020

2020

2020

2020

2020

2020

2020

2020

2020

2020

bottom of page